The authors of the study concluded that the GLP-1 receptor agonist lixisenatide had a three-point beneficial effect, when compared with placebo, in the change over a 12-month period from a baseline value of approximately 15 points on a 132-point scale measuring motor disability. The active arm improved 0.04 points in the lixisenatide group and worsened 3.04 points in the placebo group
contortus Hematoxylin and Eosin (H&E) staining was done on the female worms treated with 1 mM of quercetin and Albendazole (0.2 mM) at room temperature and samples were stored in 99.9% ethanol (MERCK)
(PubMed) Wang Z, Tang WH, Buffa JA, et al
Lyme arthritis resolution with antiserum to a 37-kilodalton Borrelia burgdorferi protein
W.YuC.ChristyR
Hormone therapies and GLP-1 treatments work well together for many patients, helping them achieve a healthy weight and body composition while increasing energy, restoring fertility, supporting sleep, enhancing drive, and more